MedTrace Logo

Sleep Homeostasis in Parkinson's Disease

NCT02200887 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2018-04-09

No results posted yet for this study

Summary

Parkinson's disease is characterized in the advanced phases by an altered response to dopaminergic therapy for the occurrence of abnormal movements called dyskinesias, that worsens the quality of life of the patient and exposes him to comorbidities. Several data show a reduction in the amount of slow wave sleep that correlates inversely with disease duration. Since this stage of sleep is linked to mechanisms of deletion of superfluous information the investigators hypothesize that the onset of dyskinesias is related to such alteration of sleep.

-This study is aimed to investigate, by means of high-density electroencephalography (hd-EEG), the sleep and in particular the slow wave in order to clarify the relations with the development of dyskinesias.

Conditions

  • Parkinson Disease

Sponsors & Collaborators

  • Salvatore Galati

    lead OTHER_GOV

Principal Investigators

  • Salvatore Galati, MD · Ospedale Regionale di Lugano

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02200887 on ClinicalTrials.gov